MedMira's Biosensor Division to Receive $3 million from ACOA's Atlantic Innovation Fund
Investment in Maple Biosciences Shall Support Development of Revolutionary Diagnostics
The Atlantic Innovation Fund is a Government of Canada initiative designed to increase leading edge research and development (R&D) carried out in Atlantic Canadian research facilities, which will lead to the launch of new ideas, products, processes and services and contribute directly to the development of new technology-based economic activity. The investment from the Atlantic Innovation Fund will support the development of new diagnostic instruments based on Maple Bioscience's biosensor technology. According to the company, these new diagnostics instruments shall displace the current 30-year old technology and play an important role in the global laboratory diagnostics market sector, currently valued at over USD $22 billion.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.